Current status and future directions in the pharmacotherapy of epilepsy

Trends in Pharmacological Sciences

Volumn 23, Issue 3, 2002, Pages 113-118

  Löscher, Wolfgang ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

DISEASE COURSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; EPILEPSY; EPILEPTOGENESIS; HEAD INJURY; HUMAN; KINDLING; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROGENOTE; RASH; REVIEW; SEIZURE;

ANTICONVULSANTS; DRUG DESIGN; DRUG RESISTANCE, MULTIPLE; EPILEPSY; HUMANS; MUTATION; P-GLYCOPROTEIN;

EID: 0036499726     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01974-X     Document Type: Review

References (37)

1. Epilepsy
2. Emerging insights into the genesis of epilepsy
3. Causes of epilepsy: Contributions of the Rochester epidemiology project
4. Advances in the medical treatment of epilepsy
5. New anti-epileptic drugs for the 21st century
6. Clinical aspects and biological bases of drug-resistant epilepsies
7. Early identification of refractory epilepsy
8. Do we need any more new antiepileptic drugs?
9. Surgical treatment of epilepsy
10. New visions in the pharmacology of anticonvulsion
11. Preventing post-traumatic epilepsy after brain injury: Weighing the costs and benefits of anticonvulsant prophylaxis
12. Antiepileptogenic agents: How close are we?
13. Strategies in antiepileptic drug development: Is rational drug design superior to random screening and structural variation?
14. Mechanisms of action of new antiepileptic drugs: Rational design and serendipitous findings
15. The process of epileptogenesis: A pathophysiological approach
16. Identification and preclinical testing of novel antiepileptic compounds
17. Responses to NMDA receptor antagonists altered by epileptogenesis
18. Animal models of epilepsy and epileptic seizures
19. Evaluation of associated behavioral and cognitive deficits in anticonvulsant drug testing
20. Genetic susceptibility to adverse drug reactions
21. The pharmacological basis of contemporary pain management
22. The evolving role of antiepileptic drugs in treating neuropathic pain
23. Novel treatments for bipolar disorder
24. Kindling: Separate vs. shared mechanisms in affective disorders and epilepsy
25. Do the epilepsies, pain syndromes and affective disorders share common, kindling-like mechanisms?
26. Patients with refractory seizures
27. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs
28. Animal models of intractable epilepsy
29. Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy
30. Comparison of valproate and phenobarbital treatment after status epilepticus in rats
31. GABA receptor function and epilepsy
32. Epilepsy-associated plasticity in gamma-aminobutyric acid receptor expression, function, and inhibitory synaptic properties
33. Recent advances in the genetics of epilepsy: Insights from human and animal studies
34. Genetics of the epilepsies
35. Ion channels and epilepsy in man and mouse
36. Single-gene models of epilepsy
37. Detecting genes in new and old mouse models for epilepsy: A prospectus through the magnifying glass